|
Pequeux, C; Keegan, B P; Hagelstein, M-T et al. (2004) Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway. Endocr Relat Cancer 11:871-85
|
|
North, William G; Wells, Wendy; Fay, Michael J et al. (2003) Immunohistochemical evaluation of vasopressin expression in breast fibrocystic disease and ductal carcinoma in situ (DCIS). Endocr Pathol 14:257-62
|
|
Keegan, Brendan P; Memoli, Vincent A; North, William G (2002) Targeting the neurophysin-related cell surface antigen on small cell lung cancer cells using a monoclonal antibody against the glycopeptide region (MAG-1) of provasopressin. Mol Cancer Ther 1:1153-9
|
|
Du, J; Keegan, B P; North, W G (2001) Key peptide processing enzymes are expressed by breast cancer cells. Cancer Lett 165:211-8
|
|
North, W G (2000) Gene regulation of vasopressin and vasopressin receptors in cancer. Exp Physiol 85 Spec No:27S-40S
|
|
North, W G; Fay, M J; Du, J (1999) MCF-7 breast cancer cells express normal forms of all vasopressin receptors plus an abnormal V2R. Peptides 20:837-42
|
|
North, W G; Fay, M J; Longo, K A et al. (1998) Expression of all known vasopressin receptor subtypes by small cell tumors implies a multifaceted role for this neuropeptide. Cancer Res 58:1866-71
|
|
North, W G; Fay, M J; Du, J (1998) All three vasopressin receptor sub-types are expressed by small-cell carcinoma. Adv Exp Med Biol 449:335-8
|
|
North, W G; Du, J (1998) Key peptide processing enzymes are expressed by a variant form of small-cell carcinoma of the lung. Peptides 19:1743-7
|
|
Maxuitenko, Y Y; North, W G; Roebuck, B D (1997) Urinary taurine as a non-invasive marker of aflatoxin B1-induced hepatotoxicity: success and failure. Toxicology 118:159-69
|
Showing the most recent 10 out of 36 publications
